Van ECK Associates Corp raised its holdings in Cognex Co. (NASDAQ:CGNX) by 27.4% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 14,264 shares of the scientific and technical instruments company’s stock after purchasing an additional 3,068 shares during the period. Van ECK Associates Corp’s holdings in Cognex were worth $1,199,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also modified their holdings of CGNX. Newfound Research LLC acquired a new stake in Cognex in the second quarter valued at approximately $42,000. O Shaughnessy Asset Management LLC boosted its stake in shares of Cognex by 185.4% in the second quarter. O Shaughnessy Asset Management LLC now owns 722 shares of the scientific and technical instruments company’s stock worth $61,000 after acquiring an additional 469 shares during the last quarter. Loomis Sayles & Co. L P acquired a new stake in shares of Cognex in the first quarter worth approximately $77,000. Patriot Financial Group Insurance Agency LLC acquired a new stake in shares of Cognex in the second quarter worth approximately $105,000. Finally, Wagner Wealth Management LLC acquired a new stake in shares of Cognex in the first quarter worth approximately $108,000. 88.25% of the stock is currently owned by institutional investors.
In related news, Director Patrick Alias sold 17,500 shares of the business’s stock in a transaction on Tuesday, August 24th. The stock was sold at an average price of $87.19, for a total transaction of $1,525,825.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Anthony Sun sold 30,000 shares of the business’s stock in a transaction on Wednesday, September 8th. The stock was sold at an average price of $86.41, for a total value of $2,592,300.00. Following the transaction, the director now directly owns 337,262 shares of the company’s stock, valued at $29,142,809.42. The disclosure for this sale can be found here. 3.90% of the stock is currently owned by insiders.
NASDAQ:CGNX opened at $85.08 on Wednesday. Cognex Co. has a 52 week low of $59.86 and a 52 week high of $101.82. The company has a market capitalization of $15.03 billion, a P/E ratio of 50.05 and a beta of 1.65. The stock’s fifty day moving average is $86.47 and its two-hundred day moving average is $83.04.
Cognex (NASDAQ:CGNX) last posted its earnings results on Thursday, August 5th. The scientific and technical instruments company reported $0.43 EPS for the quarter, beating the Zacks’ consensus estimate of $0.38 by $0.05. Cognex had a return on equity of 21.92% and a net margin of 30.96%. The company had revenue of $269.16 million for the quarter, compared to the consensus estimate of $263.11 million. Equities analysts expect that Cognex Co. will post 1.39 EPS for the current year.
The company also recently disclosed a quarterly dividend, which was paid on Friday, September 3rd. Investors of record on Friday, August 20th were issued a $0.06 dividend. The ex-dividend date of this dividend was Thursday, August 19th. This represents a $0.24 annualized dividend and a dividend yield of 0.28%. Cognex’s dividend payout ratio is presently 24.00%.
Cognex Corp. engages in the provision of machine vision products that capture and analyze visual information in order to automate tasks in processes, where vision is required. The company was founded by Robert J. Shillman, William Silver and Marilyn Matz in 1981 and is headquartered in Natick, MA.
See Also: What is a Reverse Stock Split?
Want to see what other hedge funds are holding CGNX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cognex Co. (NASDAQ:CGNX).
Receive News & Ratings for Cognex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex and related companies with MarketBeat.com's FREE daily email newsletter.